Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 62

Sort by

Sort Order Select

Journal Articles

Mitigation of Venous Thromboembolism Risk through Favorable Lifestyle: The ARIC Study

Christina Evans, MPH,MD, Ching-Png Hong, Aaron R Folsom, MD, Susan Heckbert, MD PhD, Nicholas Smith, PhD, Kerri Wiggins, MS, Mary Cushman, MD

Blood (2019) 134 (Supplement_1): 1151.

https://doi.org/10.1182/blood-2019-131290

Published: 2019

Journal Articles

To Study the Coagulation Profile Derangements in Metabolic Syndrome

Jitender Khunger, Monica Malhotra, MD, Nitin Kumar, MD, VPS Punia, MD, Mohan Agarwal, MD

Blood (2019) 134 (Supplement_1): 4959.

https://doi.org/10.1182/blood-2019-125048

Published: 2019

Journal Articles

Glucose Metabolism in Sickle Cell Disease

Taif Hassan, Binal N. Shah, Xu Zhang, PhD, Victor R Gordeuk, MD

Blood (2019) 134 (Supplement_1): 4830.

https://doi.org/10.1182/blood-2019-131485

Published: 2019

Journal Articles

Relation of Pancreatic Iron Overload Detected By MRI with Disorders of Glucose Metabolism and Results of Liver, Cardiac and Pitutiary MRI Among Transfusion Dependent Thalassemia (TDT) Patients in Turkey

Zeynep Karakas, Cihangir Sevimli, Nurdan Gul, Rana Comert, Memduh Dursun

Blood (2018) 132 (Supplement 1): 2350.

https://doi.org/10.1182/blood-2018-99-115356

Published: 2018

Journal Articles

Jadenu Substituting Exjade in Beta Thalassemia Major (BTM) Patients with Iron Overload: Effect on Serum Ferritin Concentration, Liver Iron Content and Biochemical Profiles

Mohamed A Yassin, MBBS, MSc, Abdulqadir Nashwan, MSc, Nancy Kassem, BSC, Ashraf Tawfiq Soliman, MD PhD, Vincenzo De Sanctis, Ahmed A Adel, BSC, Radwa M Hussein, BSC, Ahmed Basha, BSC, Randa Al -Okka, BSC, Rula Ghasoub, BSC

Blood (2018) 132 (Supplement 1): 4905.

https://doi.org/10.1182/blood-2018-99-113998

Published: 2018

Journal Articles

An Urgent Need for Improving Thalassemia Care in Adult Patients Due to a Wide Gap on Current Real-Life Practice and Recommended Clinical Practice Guidelines

Supachai Ekwattanakit, BSc, PhD MD, Chattree Hantaweepant, MD, Archrob Khuhapinant, MD PhD, Noppadol Siritanaratkul, MD, Vip Viprakasit, MD DPhil

Blood (2017) 130 (Supplement 1): 952.

https://doi.org/10.1182/blood.V130.Suppl_1.952.952

Published: 2017

Journal Articles

Type 2 Diabetes Mellitus Strongly Impacts Survival in Patients with Diffuse Large B Cell Lymphoma

Rui Gao, MD, Wei Xu, MDPhD, Jin-Hua Liang, MD, Li Wang, MD, Lei Fan, MD PhD, Tao Yang, MD PhD, Jian-Yong Li, MD PhD

Blood (2017) 130 (Supplement 1): 2848.

https://doi.org/10.1182/blood.V130.Suppl_1.2848.2848

Published: 2017

Journal Articles

a Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (NHL)

Kami J. Maddocks, MD, Jonathon B. Cohen, MD, Ying Huang, MA, MS, Beth A Christian, MD, Don M Benson, MD PhD, Jeffrey Jones, MD MPH, Christopher Flowers, MD MS, Leonard T. Heffner, MD, Cynthia Jenkins, RN, Jennfer Sexton, MHA, CCRC, Alison Neal, MPH, Melissa Kives, MPH, Kristie A. Blum, MD

Blood (2016) 128 (22): 1776.

https://doi.org/10.1182/blood.V128.22.1776.1776

Published: 2016

Journal Articles

Metabolic Syndrome in Long-Term Survivors of Childhood Acute Leukemia Treated without Hematopoietic Stem Cell Transplantation: An L.E.Α. Study

Blood (2016) 128 (22): 695.

https://doi.org/10.1182/blood.V128.22.695.695

Published: 2016

Journal Articles

A Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma (NHL)

Kami J. Maddocks, MD, Jonathon B. Cohen, MD, Beth A Christian, MD, Don M Benson, MD PhD, Kristie A. Blum, MD

Blood (2015) 126 (23): 5114.

https://doi.org/10.1182/blood.V126.23.5114.5114

Published: 2015

Journal Articles

Metabolic Syndrome Risk Among Adults Living with Sickle Cell Disease

Shawn M Bediako, PhD, Julie Nelson, BS, Cody Cichowitz, BS, Tiffany Yu, BS, C. Patrick Carroll, MD, Kerry J. Stewart, Ed.D., Rakhi P. Naik, MD MHS, Carlton Haywood, Jr., PhD MA, Sophie Lanzkron, MD MHS

Blood (2015) 126 (23): 3405.

https://doi.org/10.1182/blood.V126.23.3405.3405

Published: 2015

Journal Articles

Prospective Metabolic and Cardiovascular Assessment in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Nilotinib 300 Mg Bid Frontline in the Gimema 0811 Trial

Blood (2015) 126 (23): 4046.

https://doi.org/10.1182/blood.V126.23.4046.4046

Published: 2015

Journal Articles

Standardized Long-Term Follow-up after Allogeneic Stem Cell Transplantation: A Cross-Sectional 1-Year Evaluation in 260 Adults

Blood (2015) 126 (23): 4362.

https://doi.org/10.1182/blood.V126.23.4362.4362

Published: 2015

Journal Articles

An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL)

Anas Younes, MD, Gilles Salles, Giovanni Martinelli, R. Gregory Bociek, MD, Dolores Caballero Barrigon, MD, Eva Gonzalez Barca, Mehmet Turgut, MD PhD, John F. Gerecitano, MD, Fabian Herbst, Lisa Williams, Nabanita Mukherjee, Ranjana Tavorath, Won Seog Kim, MD PhD

Blood (2015) 126 (23): 1493.

https://doi.org/10.1182/blood.V126.23.1493.1493

Published: 2015

Journal Articles

Hyperhomocysteinemia and High Doses of Nilotinib Favour Cardio-Vascular Events in Chronic Phase Chronic Myelogenous Leukemia (CML) Patients

Gaelle Fossard, MD, Emilie Blond, Pharm.D, Stephane Giraudier, MD PhD, Stephane Morisset, Stat., Jeremy Ruby, CRA student, Martine Escoffre-Barbe, MD, Hélène Labussière-Wallet, MD, Mael Heiblig, MD, Madeleine Etienne, CRA, Jocelyne Drai, Pharm.D, Mohamad Sobh, Pharm.M., Mauricette Michallet, MD PhD, Isabelle Redonnet-vernhet, MD PhD, Jean-christophe Lega, MD PhD, Gabriel Etienne, MD PhD, Franck E. Nicolini, MD PhD

Blood (2014) 124 (21): 3136.

https://doi.org/10.1182/blood.V124.21.3136.3136

Published: 2014

Journal Articles

Obesity and Insulin Resistance after Chemotherapy in Patients with Acute Lymphoblastic Leukemia

Yesim Oymak, MD, Belgin Uysal, MD, Tuba Hilkay Karapinar, MD, Yilmaz Ay, MD, Dilek Ince, MD PhD, Bengu Demirag, MD, Burcak Tatli Gunes, MD, Esin Albudak Ozcan, MD, Ersin Toret, MD, Sultan Aydin Koker, MD, Neryal Muminoglu, MD, Canan Vergin, MD, Korcan Demir, MD

Blood (2014) 124 (21): 5250.

https://doi.org/10.1182/blood.V124.21.5250.5250

Published: 2014

Journal Articles

Comparison of Glucose and Lipid Metabolism Abnormality during Nilotinib, Imatinib and Dasatinib Therapy – Results of Enigma 2 Study

Racil Zdenek, Petra Belohlavkova, Petr Cetkovsky, Edgar Faber, Hana Klamova, Malaskova Ludmila, Tomasz Sacha, MD PhD, Voglova Jaroslava, Daniela Zackova, Pavel Zak, Jiri Mayer

Blood (2014) 124 (21): 1813.

https://doi.org/10.1182/blood.V124.21.1813.1813

Published: 2014

Journal Articles

The Use of Biochemical Parameters Instead of MRI for the Prediction of Pancreatic Iron Loading Among Patients with β-Thalassemia Major

Munevver Bas, Fatma Gumruk, MDProf, Tuncay Hazirolan, A. Murat Tuncer, MD, Mualla Cetin, Sule Unal, MD

Blood (2014) 124 (21): 1356.

https://doi.org/10.1182/blood.V124.21.1356.1356

Published: 2014

Journal Articles

Identification and Management of Glucocorticoid-Induced Hyperglycemia on an Inpatient Malignant Hematology Ward: A Quality Improvement Initiative

Andrew Aw, MDM, MEng, Heidi Dutton, MD, Janine Malcolm, MD, Erin Keely, MD, Jason Tay, MD MSc

Blood (2014) 124 (21): 6004.

https://doi.org/10.1182/blood.V124.21.6004.6004

Published: 2014

Journal Articles

Periodic Monitoring of Components of the Metabolic Syndrome in Adolescent Survivors of Childhood Cancer

Young-Ho Lee, MD PhD, HyeKyung Shin, MD, Hye-Roung Kang, Seung Yang, MD, PhD

Blood (2014) 124 (21): 6012.

https://doi.org/10.1182/blood.V124.21.6012.6012

Published: 2014

NARROW

Mitigation of Venous Thromboembolism Risk through Favorable Lifestyle: The ARIC Study

To Study the Coagulation Profile Derangements in Metabolic Syndrome

Glucose Metabolism in Sickle Cell Disease

Relation of Pancreatic Iron Overload Detected By MRI with Disorders of Glucose Metabolism and Results of Liver, Cardiac and Pitutiary MRI Among Transfusion Dependent Thalassemia (TDT) Patients in Turkey

Jadenu Substituting Exjade in Beta Thalassemia Major (BTM) Patients with Iron Overload: Effect on Serum Ferritin Concentration, Liver Iron Content and Biochemical Profiles

An Urgent Need for Improving Thalassemia Care in Adult Patients Due to a Wide Gap on Current Real-Life Practice and Recommended Clinical Practice Guidelines

Type 2 Diabetes Mellitus Strongly Impacts Survival in Patients with Diffuse Large B Cell Lymphoma

a Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (NHL)

Metabolic Syndrome in Long-Term Survivors of Childhood Acute Leukemia Treated without Hematopoietic Stem Cell Transplantation: An L.E.Α. Study

A Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma (NHL)

Metabolic Syndrome Risk Among Adults Living with Sickle Cell Disease

Prospective Metabolic and Cardiovascular Assessment in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Nilotinib 300 Mg Bid Frontline in the Gimema 0811 Trial

Standardized Long-Term Follow-up after Allogeneic Stem Cell Transplantation: A Cross-Sectional 1-Year Evaluation in 260 Adults

An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL)

Hyperhomocysteinemia and High Doses of Nilotinib Favour Cardio-Vascular Events in Chronic Phase Chronic Myelogenous Leukemia (CML) Patients

Obesity and Insulin Resistance after Chemotherapy in Patients with Acute Lymphoblastic Leukemia

Comparison of Glucose and Lipid Metabolism Abnormality during Nilotinib, Imatinib and Dasatinib Therapy – Results of Enigma 2 Study

The Use of Biochemical Parameters Instead of MRI for the Prediction of Pancreatic Iron Loading Among Patients with β-Thalassemia Major

Identification and Management of Glucocorticoid-Induced Hyperglycemia on an Inpatient Malignant Hematology Ward: A Quality Improvement Initiative

Periodic Monitoring of Components of the Metabolic Syndrome in Adolescent Survivors of Childhood Cancer

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only